Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138073 · ClinicalTrials.gov registry record · NA
Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT00138073: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT00138073 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00138073, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Skill with pulmonary artery catheter (PAC) waveform interpretation is inadequate among physicians and nurses. We, the investigators at Massachusetts General Hospital, have developed a web-based computer program to assist physicians and nurses in PAC waveform interpretation. We will study the effectiveness of this program on improving the interpretation of waveforms on a computer-based test.
Primary Outcome
The study was terminated before the primary outcome could be measured. None of the participants took the post-intervention test.
Interventions
- DEVICE Web-based waveform interpretation guide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2005-12 |
| Est. Completion | 2012-04 |
| Phase | NA |
Why NCT00138073 stopped before completion
NCT00138073 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Web-based waveform interpretation guide is the first listed.
NCT00138073 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00138073 about?
NCT00138073 is a clinical study titled "Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation". Skill with pulmonary artery catheter (PAC) waveform interpretation is inadequate among physicians and nurses. We, the investigators at Massachusetts General Hospital, have developed a web-based computer program to assist physicians and nurses in PAC waveform interpretation. We will study the effecti...
What is the current status of trial NCT00138073?
This trial is currently terminated. It is a NA study. The enrollment target is 55 participants. The study started on 2005-12. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00138073?
The interventions under investigation include: Web-based waveform interpretation guide (DEVICE).
Who is sponsoring clinical trial NCT00138073?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00138073's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia